论文部分内容阅读
目的分析厄贝沙坦治疗糖尿病高血压的临床效果。方法 250例糖尿病高血压患者,通过随机数表法分为治疗组和对照组,各125例。对照组患者给予苯磺酸左旋氨氯地平治疗;治疗组则应用厄贝沙坦。对比两组患者的治疗总有效率以及24 h尿微量白蛋白(UMA)、血压改善情况。结果治疗组患者的治疗总有效率明显高于对照组,差异具有统计学意义(P<0.05);治疗后两组患者血压、24 h尿UMA水平均得到一定程度的改善,且治疗组患者的改善程度优于对照组,差异具有统计学意义(P<0.05)。结论相对于苯磺酸左旋氨氯地平,应用厄贝沙坦治疗高血压糖尿病的效果佳,具有较高的推广价值。
Objective To analyze the clinical effect of irbesartan in the treatment of diabetic hypertension. Methods 250 cases of diabetic hypertensive patients were divided into treatment group and control group by random number table, each of 125 cases. Patients in the control group were treated with levamlodipine besylate; irbesartan was used in the treatment group. The total effective rate was compared between two groups of patients and 24 h urinary microalbuminuria (UMA), blood pressure to improve the situation. Results The total effective rate of treatment group was significantly higher than that of control group (P <0.05). After treatment, the blood pressure and 24-hour urinary UMA levels of both groups were improved to a certain extent, and the patients in treatment group The improvement was better than the control group, the difference was statistically significant (P <0.05). Conclusion Compared with levamlodipine besylate, the application of irbesartan in the treatment of hypertensive diabetic patients with good results, with a high promotional value.